Bristol-Myers Squibb (BMY)
64.40
-0.02 -0.03%
NYSE
Oct 23, 09:37
Delayed 2m
USD
View All Key Stats
BMY Key Stats
| Income Statement | |
| Revenue (TTM) | 20.24B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.75 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 4.586B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.63% |
| Profit Margin (Quarterly) | 17.81% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.42% |
| Price and Valuation | |
| Market Cap | 105.61B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.317 |
| PE Ratio (TTM) | 23.42 |
| Price to Book Value | 7.185 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.559 |
| Free Cash Flow (Quarterly) | 1.336B |
| Return on Equity (TTM) | 30.24% |
View All BMY News
BMY News
-
WireHeadlineTime (ET)
-
PR Newswire10/23 06:10
-
Yahoo10/20 17:28
-
Yahoo10/20 08:47
-
MT Newswires10/20 07:34
-
Business Wire10/20 06:59
-
Yahoo10/18 16:21
-
Yahoo10/18 09:12
-
Yahoo10/18 09:10
-
Yahoo10/18 08:00
-
Yahoo10/17 17:00
View All Events
BMY Events
| Date | Type | Description |
|---|---|---|
| 10/26/2018 | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call in 2018 |
| 10/26/2018 | Earnings | Bristol-Myers Squibb Co Third Quarter Earnings Results in 2018 |
| 07/27/2018 | Misc | Bristol-Myers Squibb Co Second Quarter Earnings Conference Call in 2018 |
| 07/27/2018 | Earnings | Bristol-Myers Squibb Co Second Quarter Earnings Results in 2018 |
| 05/02/2018 | Misc | Bristol-Myers Squibb Co Annual General Meeting in 2017 |
| 04/27/2018 | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2018 |
| 04/27/2018 | Earnings | Bristol-Myers Squibb Co First Quarter Earnings Results in 2018 |
| 02/21/2018 | Misc | Bristol-Myers Squibb Co Annual Report in 2017 |
| 01/26/2018 | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call in 2017 |
| 01/26/2018 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings Results in 2017 |
BMY Fundamentals
Income Statement View Statement
BMY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMY One Page Reports
- One Page Report Download
BMY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 64.40 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Growth
- Next Earnings Release: Oct. 26, 2017
- Last Earnings Release: Jul. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Oct. 05, 2017
- Description: Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.
BMY Comparables
EditBMY Excel Add-In Codes
- Name: =YCI("BMY","name")
- Description: =YCI("BMY","description")
- Sector: =YCI("BMY","sector")
- Industry: =YCI("BMY","industry")
- Est. Current Fiscal Year End: =YCI("BMY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
